Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 2/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | PYGL | P06737 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8918703 | 0.90 | ALDH1A1 (0.41) | ADH1AL3MBTL1LMNAHSD11B1PYGL | |
| SCHEMBL27574205 | 0.87 | NAAA (0.43) | ADH1AADH1C | |
| SCHEMBL968899 | 0.85 | L3MBTL1 (0.46) | ADH1AADH1CL3MBTL1MEN1KMT2A | |
| SCHEMBL13911238 | 0.84 | ADH1A (0.43) | ADH1AADH1CL3MBTL1MEN1KMT2A | |
| SCHEMBL970246 | 0.83 | L3MBTL1 (0.44) | ADH1AADH1CCCR5L3MBTL1MEN1 | |
| SCHEMBL7563693 | 0.83 | EPHX1 (0.47) | ADH1AADH1CL3MBTL1MEN1KMT2A | |
| SCHEMBL13911276 | 0.83 | ADH1A (0.42) | ADH1AADH1CCCR5MEN1KMT2A | |
| SCHEMBL969305 | 0.81 | L3MBTL1 (0.41) | ADH1AADH1CCCR5L3MBTL1MEN1 | |
| SCHEMBL9837028 | 0.79 | ADH1A (0.48) | ADH1AADH1CL3MBTL1MEN1KMT2A | |
| SCHEMBL4281691 | 0.79 | ADH1A (0.48) | ADH1AADH1CL3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10779540-B2 | Benzamide compounds and their use as herbicides | BASF SE (DE) | 2020-09-22 | — | — | US | disclosed |
| EP-3390372-B1 | BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2020-06-03 | — | — | EP | disclosed |
| WO-2017102275-A1 | BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2017-06-22 | — | — | WO | disclosed |
| US-7504391-B2 | Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders | SCHERING CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| US-5459147-A | Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma | DR. KARL THOMAE GMBH (DE) | 1995-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10779540-B2 | Benzamide compounds and their use as herbicides | DDT, DNPH1, BBOX1 | ADH1A 324/4885ADH1C 286/4885CCR5 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.